$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

$vrtx Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000087532019000019 Filed on May 01, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$858.4M	$640.8M
YoY Change	33.96%	-10.34%
Cost Of Revenue	$95.09M	$71.61M
YoY Change	32.79%	52.41%
Gross Profit	$763.3M	$569.2M
YoY Change	34.11%	-14.76%
Gross Profit Margin	88.92%	88.82%
Selling, General & Admin	$147.0M	$129.8M
YoY Change	13.28%	14.54%
% of Gross Profit	19.26%	22.81%
Research & Development	$339.5M	$310.6M
YoY Change	9.32%	13.52%
% of Gross Profit	44.47%	54.56%
Depreciation & Amortization	$27.14M	$16.34M
YoY Change	66.06%	10.05%
% of Gross Profit	3.56%	2.87%
Operating Expenses	$486.5M	$440.4M
YoY Change	10.49%	13.82%
Operating Profit	$276.8M	$128.9M
YoY Change	114.74%	-52.41%
Interest Expense	$14.87M	$16.89M
YoY Change	-11.95%	-200.72%
% of Operating Profit	5.37%	13.1%
Other Income/Expense, Net	$42.61M	$96.84M
YoY Change	-56.0%	-17901.1%
Pretax Income	$320.2M	$214.6M
YoY Change	49.16%	-15.34%
Income Tax	$51.53M	-$12.66M
% Of Pretax Income	16.1%	-5.9%
Net Earnings	$268.6M	$210.3M
YoY Change	27.76%	-15.13%
Net Earnings / Revenue	31.29%	32.81%
Basic Earnings Per Share	$1.05	$0.83
Diluted Earnings Per Share	$1.03	$0.81
COMMON SHARES
Basic Shares Outstanding	255.7M shares	253.2M shares
Diluted Shares Outstanding	260.2M shares	258.5M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.478B	$2.477B
YoY Change	40.41%	75.8%
Cash & Equivalents	$2.894B	$1.996B
Short-Term Investments	$584.0M	$481.0M
Other Short-Term Assets	$130.0M	$119.0M
YoY Change	9.24%	-31.21%
Inventory	$136.7M	$111.7M
Prepaid Expenses
Receivables	$438.3M	$311.2M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.183B	$3.041B
YoY Change	37.55%	62.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$758.1M	$800.7M
YoY Change	-5.32%	13.03%
Goodwill	$50.38M	$50.40M
YoY Change	-0.03%	0.03%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$39.04M	$31.80M
YoY Change	22.75%	176.7%
Total Long-Term Assets	$2.079B	$517.5M
YoY Change	301.71%	-51.85%
TOTAL ASSETS
Total Short-Term Assets	$4.183B	$3.041B
Total Long-Term Assets	$2.079B	$517.5M
Total Assets	$6.262B	$3.559B
YoY Change	75.96%	20.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$82.26M	$74.06M
YoY Change	11.07%	17.29%
Accrued Expenses	$532.7M	$452.5M
YoY Change	17.72%	62.81%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$36.00M	$17.00M
YoY Change	111.76%	-10.53%
Total Short-Term Liabilities	$1.106B	$827.3M
YoY Change	33.74%	68.91%
LONG-TERM LIABILITIES
Long-Term Debt	$560.0M	$578.0M
YoY Change	-3.11%	9.26%
Other Long-Term Liabilities	$70.23M	$27.46M
YoY Change	155.72%	-3.53%
Total Long-Term Liabilities	$70.23M	$27.46M
YoY Change	155.72%	-3.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.106B	$827.3M
Total Long-Term Liabilities	$70.23M	$27.46M
Total Liabilities	$1.820B	$1.522B
YoY Change	19.55%	20.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.030B	-$5.111B
YoY Change	-40.73%	-0.47%
Common Stock	$7.478B	$7.317B
YoY Change	2.21%	10.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.723B	$2.401B
YoY Change
Total Liabilities & Shareholders Equity	$6.262B	$3.559B
YoY Change	75.96%	20.77%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$268.6M	$210.3M
YoY Change	27.76%	-15.13%
Depreciation, Depletion And Amortization	$27.14M	$16.34M
YoY Change	66.06%	10.05%
Cash From Operating Activities	$324.8M	$252.7M
YoY Change	28.55%	-4.91%
INVESTING ACTIVITIES
Capital Expenditures	$18.04M	$29.28M
YoY Change	-38.38%	163.8%
Acquisitions
YoY Change
Other Investing Activities	-$21.10M	$34.20M
YoY Change	-161.7%	-57100.0%
Cash From Investing Activities	-$39.14M	$4.933M
YoY Change	-893.39%	-103.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$94.01M	$10.00M
YoY Change	840.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$41.99M	$78.96M
YoY Change	-153.18%	-127.27%
NET CHANGE
Cash From Operating Activities	$324.8M	$252.7M
Cash From Investing Activities	-$39.14M	$4.933M
Cash From Financing Activities	-$41.99M	$78.96M
Net Change In Cash	$243.3M	$338.2M
YoY Change	-28.07%	-284.34%
FREE CASH FLOW
Cash From Operating Activities	$324.8M	$252.7M
Capital Expenditures	$18.04M	$29.28M
Free Cash Flow	$306.7M	$223.4M
YoY Change	37.32%	-12.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000875320
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	256121360	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	VERTEX PHARMACEUTICALS INC / MA
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	110987000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	82262000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	409688000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2901532000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	338202000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	438297000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	604495000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	532745000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	659000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	6000000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7421476000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7475909000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78601000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	94243000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	78136000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	93791000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	56277000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	54267000	USD
CY2018Q4	us-gaap	Assets Assets	6245898000	USD
CY2019Q1	us-gaap	Assets Assets	6543114000	USD
CY2019Q1	us-gaap	Assets Assets	6261958000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	3843109000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	4183039000	USD
CY2018Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1648745000	USD
CY2019Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	1786188000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	24000000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	9817000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	19658000	USD
CY2018Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	94800000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	32060000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	1974000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	3300000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5649000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	7282000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	3085000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	2585000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	29475000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	10770000	USD
CY2018Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	34000000	USD
CY2018Q4	us-gaap	Cash Cash	1400000000	USD
CY2019Q1	us-gaap	Cash Cash	1500000000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1665412000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1995893000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2650134000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2893885000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1667526000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2005728000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2658253000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	243279000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	255172000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	256351000	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	255172000	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	256351000	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	2546000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	2561000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	206212000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	273972000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	17038000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	223250000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	273972000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24900000	USD
CY2019Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	51400000	USD
CY2018Q4	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	354404000	USD
CY2019Q1	us-gaap	Contract With Customer Refund Liability Current ContractWithCustomerRefundLiabilityCurrent	382703000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	71613000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	95092000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	511898000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	581627000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	9229000	USD
CY2018Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-40310000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1499672000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1467518000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1510908000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	16343000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27140000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.83
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.05
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.81
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.03
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1656000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-378000	USD
CY2018Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-21900000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	465000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	452000	USD
CY2018Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	21859000	USD
CY2019Q1	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	39524000	USD
CY2018Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	95458000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	43551000	USD
CY2019Q1	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	13449000	USD
CY2019Q1	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	11910000	USD
CY2018Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	596638000	USD
CY2019Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	596106000	USD
CY2018Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5271000	USD
CY2019Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	35725000	USD
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	560381000	USD
CY2019Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	569487000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	919614000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	512804000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	84092000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	85016000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	87365000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	88998000	USD
CY2019Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	61339000	USD
CY2019Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	323508000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	9385000	USD
CY2018Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	640952000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	473129000	USD
CY2019Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	12365000	USD
CY2019Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0911
CY2019Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P10Y5M12D
CY2018Q4	us-gaap	Goodwill Goodwill	50384000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	50384000	USD
CY2018Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2019Q1	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	214642000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	320165000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12700000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-12659000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51534000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	51500000	USD
CY2018Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1897000	USD
CY2019Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1835000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2154000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-24145000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13473000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	30136000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-31469000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-38425000	USD
CY2018Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	38816000	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	35683000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8208000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13139000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	80529000	USD
CY2018Q1	us-gaap	Inventory Write Down InventoryWriteDown	3619000	USD
CY2019Q1	us-gaap	Inventory Write Down InventoryWriteDown	1270000	USD
CY2018Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	5789000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	3587000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	43425000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-25482000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7941000	USD
CY2019Q1	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	0	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	34000	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	25000	shares
CY2018Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-16886000	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-14868000	USD
CY2018Q1	us-gaap	Interest Paid Net InterestPaidNet	16825000	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	13148000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	26739000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	44520000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	124360000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	136698000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9677000	USD
CY2019Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11649000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	87944000	USD
CY2019Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	15615000	USD
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4600000	USD
CY2019Q1	us-gaap	Lease Cost LeaseCost	33731000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	88951000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	46212000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	8151000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8233000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	8658000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10366000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	7331000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	17947000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	1810695000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	1819801000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6245898000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6543114000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6261958000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1120292000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1106468000	USD
CY2018Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	518108000	USD
CY2019Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	584150000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78956000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-41989000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4933000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39138000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	252657000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	60573000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	61674000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	63484000	USD
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	64849000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	324784000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	210263000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2531000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	268631000	USD
CY2018Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	17038000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	210164000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	268631000	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	210166000	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	268631000	USD
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	3716000	USD
CY2019Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2019Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	128901000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	276808000	USD
CY2019Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	2639000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	71004000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7520000	USD
CY2019Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0405
CY2019Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y10M28D
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1038325000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	94071000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	93761000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	94245000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	95986000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	575191000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	85071000	USD
CY2018	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	6200000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	40728000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	39041000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax	-222000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2729000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4967000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-4051000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	5341000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-862000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	300000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	1500000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-460000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	596000	USD
CY2019Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	108758000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26280000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18041000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5997000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5377000	USD
CY2018Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5827000	USD
CY2019Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3701000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	96838000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	42610000	USD
CY2018Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	10000000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	99839000	USD
CY2018Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	38653000	USD
CY2019Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	128215000	USD
CY2018Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	21500000	USD
CY2019Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29279000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	140819000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	130009000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	137889000	USD
CY2018Q1	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	9566000	USD
CY2019Q1	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	0	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	88403000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	63620000	USD
CY2016Q4	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	300000000	USD
CY2018Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-1000000	USD
CY2019Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2018Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	94365000	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	107118000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	227301000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	268631000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	812005000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	742559000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	758085000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	310553000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	339490000	USD
CY2018Q1	us-gaap	Restructuring Charges RestructuringCharges	-76000	USD
CY2019Q1	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2989478000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2761157000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3029788000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	640799000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	858435000	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	129808000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	147045000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	78136000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	93791000	USD
CY2019Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	4412000	shares
CY2019Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	8702000	shares
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	78136000	USD
CY2019Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	93791000	USD
CY2019Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	100.04
CY2019Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	124.11
CY2019Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y3M11D
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	89686000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	64044000	USD
CY2018Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	11251000	USD
CY2019Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	103839000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2042306000	USD
CY2018Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2430821000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4435203000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4723313000	USD
CY2018Q1	us-gaap	Stockholders Equity Other StockholdersEquityOther	1000000	USD
CY2019Q1	us-gaap	Sublease Income SubleaseIncome	1484000	USD
CY2018Q1	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	-97000	USD
CY2019Q1	us-gaap	Undistributed Earnings Diluted UndistributedEarningsDiluted	0	USD
CY2018Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	99000	USD
CY2019Q1	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2018Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	95500000	USD
CY2019Q1	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	43600000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	19500000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	25200000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	USD
CY2019Q1	us-gaap	Variable Lease Cost VariableLeaseCost	6762000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	258526000	shares
CY2018Q4	vrtx	Debt Securities Availablefor Sale Maturitywithin One Year DebtSecuritiesAvailableforSaleMaturitywithinOneYear	1647500000	USD
CY2019Q1	vrtx	Debt Securities Availablefor Sale Maturitywithin One Year DebtSecuritiesAvailableforSaleMaturitywithinOneYear	1775571000	USD
CY2018Q4	vrtx	Debtand Equity Securities Cost DebtandEquitySecuritiesCost	484473000	USD
CY2019Q1	vrtx	Debtand Equity Securities Cost DebtandEquitySecuritiesCost	506368000	USD
CY2018Q4	vrtx	Debtand Equity Securities Fair Value DebtandEquitySecuritiesFairValue	518108000	USD
CY2019Q1	vrtx	Debtand Equity Securities Fair Value DebtandEquitySecuritiesFairValue	584150000	USD
CY2018Q4	vrtx	Debtand Equity Securities Unrealized Gain DebtandEquitySecuritiesUnrealizedGain	40646000	USD
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	260175000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	253231000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	255695000	shares
CY2018Q1	vrtx	Accrued Share Repurchase Liability AccruedShareRepurchaseLiability	0	USD
CY2019Q1	vrtx	Accrued Share Repurchase Liability AccruedShareRepurchaseLiability	4000000	USD
CY2018Q4	vrtx	Advanced Funding Received From Collaborator AdvancedFundingReceivedFromCollaborator	82573000	USD
CY2019Q1	vrtx	Advanced Funding Received From Collaborator AdvancedFundingReceivedFromCollaborator	83471000	USD
CY2018Q4	vrtx	Capital Lease Obligationand Construction Financing Obligation Noncurrent CapitalLeaseObligationandConstructionFinancingObligationNoncurrent	581550000	USD
CY2018Q4	vrtx	Construction Financing Obligation Noncurrent ConstructionFinancingObligationNoncurrent	561892000	USD
CY2018Q4	vrtx	Contingent Liabilities ContingentLiabilities	0	USD
CY2019Q1	vrtx	Contingent Liabilities ContingentLiabilities	0	USD
CY2018Q4	vrtx	Debt Securities Availablefor Sale Maturityafter One Year Through Five Years DebtSecuritiesAvailableforSaleMaturityafterOneYearThroughFiveYears	1245000	USD
CY2019Q1	vrtx	Debt Securities Availablefor Sale Maturityafter One Year Through Five Years DebtSecuritiesAvailableforSaleMaturityafterOneYearThroughFiveYears	10617000	USD
CY2019Q1	vrtx	Debtand Equity Securities Unrealized Gain DebtandEquitySecuritiesUnrealizedGain	79217000	USD
CY2018Q4	vrtx	Debtand Equity Securities Unrealized Loss DebtandEquitySecuritiesUnrealizedLoss	7011000	USD
CY2019Q1	vrtx	Debtand Equity Securities Unrealized Loss DebtandEquitySecuritiesUnrealizedLoss	1435000	USD
CY2018Q1	vrtx	Employee Benefit Plan Payable Receivable EmployeeBenefitPlanPayableReceivable	2124000	USD
CY2019Q1	vrtx	Employee Benefit Plan Payable Receivable EmployeeBenefitPlanPayableReceivable	510000	USD
CY2018Q4	vrtx	Finance Lease Right Of Use Asset Gross FinanceLeaseRightOfUseAssetGross	640952000	USD
CY2019Q1	vrtx	Finance Lease Right Of Use Asset Gross FinanceLeaseRightOfUseAssetGross	473129000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability FinanceLeaseandOperatingLeaseLiability	667110000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Payment Due Year Three FinanceLeaseandOperatingLeaseLiabilityPaymentDueYearThree	96023000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Payment Due Year Two FinanceLeaseandOperatingLeaseLiabilityPaymentDueYearTwo	99364000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Payments Due FinanceLeaseandOperatingLeaseLiabilityPaymentsDue	1008565000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Payments Due After Year Five FinanceLeaseandOperatingLeaseLiabilityPaymentsDueAfterYearFive	559016000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Payments Due Year Five FinanceLeaseandOperatingLeaseLiabilityPaymentsDueYearFive	92243000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Payments Due Year Four FinanceLeaseandOperatingLeaseLiabilityPaymentsDueYearFour	93249000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Payments Remainderof Fiscal Year FinanceLeaseandOperatingLeaseLiabilityPaymentsRemainderofFiscalYear	68670000	USD
CY2019Q1	vrtx	Finance Leaseand Operating Lease Liability Undiscounted Excess Amount FinanceLeaseandOperatingLeaseLiabilityUndiscountedExcessAmount	341455000	USD
CY2019Q1	vrtx	Indemnification Claims IndemnificationClaims	0	USD
CY2016Q4	vrtx	Line Of Credit Facility Additional Borrowing Capacity LineOfCreditFacilityAdditionalBorrowingCapacity	300000000	USD
CY2018Q4	vrtx	Other Liabilities Excluding Capital Lease Obligations Current OtherLiabilitiesExcludingCapitalLeaseObligationsCurrent	40589000	USD
CY2019Q1	vrtx	Other Liabilities Excluding Capital Lease Obligations Current OtherLiabilitiesExcludingCapitalLeaseObligationsCurrent	74893000	USD
CY2018Q4	vrtx	Other Liabilitiesand Capital Lease Obligations Current OtherLiabilitiesandCapitalLeaseObligationsCurrent	50406000	USD
CY2018Q1	vrtx	Paymentson Capital Leaseand Construction Financing Lease Obligations PaymentsonCapitalLeaseandConstructionFinancingLeaseObligations	9331000	USD
CY2018Q1	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	2500000	USD
CY2019Q1	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	5000000	USD
CY2018Q1	vrtx	Repaymentsof Collaborative Funding RepaymentsofCollaborativeFunding	1182000	USD
CY2019Q1	vrtx	Repaymentsof Collaborative Funding RepaymentsofCollaborativeFunding	1385000	USD
CY2019Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates </font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, research and development expenses, goodwill, deferred tax asset valuation allowances and the provision for or benefit from income taxes. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div></div>

Files In Submission

Name	View Source	Status
0000875320-19-000019-index-headers.html	Edgar Link	pending
0000875320-19-000019-index.html	Edgar Link	pending
0000875320-19-000019.txt	Edgar Link	pending
0000875320-19-000019-xbrl.zip	Edgar Link	pending
a2019q110-q.htm	Edgar Link	pending
a2019q110-qexhibit102.htm	Edgar Link	pending
a2019q110-q_exhibit101.htm	Edgar Link	pending
a2019q110-q_exhibit311.htm	Edgar Link	pending
a2019q110-q_exhibit312.htm	Edgar Link	pending
a2019q110-q_exhibit321.htm	Edgar Link	pending
chart-294bf5d1ae0bd0f3296.jpg	Edgar Link	pending
chart-38e576d3dbf1c7e29bf.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrtx-20190331.xml	Edgar Link	completed
vrtx-20190331.xsd	Edgar Link	pending
vrtx-20190331_cal.xml	Edgar Link	unprocessable
vrtx-20190331_def.xml	Edgar Link	unprocessable
vrtx-20190331_lab.xml	Edgar Link	unprocessable
vrtx-20190331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

2019 Q1 Form 10-Q Financial Statement

#000087532019000019 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRTX VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

2019 Q1 Form 10-Q Financial Statement

#000087532019000019 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx